A multicentric, randomized, controlled phase III study of centhaquine (Lyfaquin®) as a resuscitative agent in hypovolemic shock patients

Data Availability

The data are not publicly available due to restrictions that could compromise the privacy of research participants. The data that support the findings of this study are available from the corresponding author, upon reasonable request. The study protocol (PMZ-2010/CT-3.1/2018) was approved by the Drug Controller General of India (DCGI), Ministry of Health and Family Welfare, Government of India and Institutional Ethics Committee of all the 14 Institutions.